Basic information Safety Supplier Related

6-Nitro-7-Chloro-4-HydroxyQuinazoline

Basic information Safety Supplier Related

6-Nitro-7-Chloro-4-HydroxyQuinazoline Basic information

Product Name:
6-Nitro-7-Chloro-4-HydroxyQuinazoline
Synonyms:
  • 6-Nitro-7-Chloro-4-HydroxyQuinazoline
  • 7-CHLORO 6-NITRO QUINAZOLINE 4-OL
  • 7-Chloro-6-nitro-4-hydroxyquinazoline
  • 6-Nitro-7-chloro-3,4-dihydroquinazolin-4-one
  • 7-Chloro-1,4-dihydro-6-nitro-4-oxoquinazoline
  • 7-Chloro-6-nitroquinazolin-4(1H)-one
  • 7-Chloro-6-nitro-4-quinazolinol
  • 7-Chloro-6-nitro-3H-quinazolin-4-one
CAS:
53449-14-2
MF:
C8H4ClN3O3
MW:
225.59
EINECS:
678-360-9
Product Categories:
  • Building Blocks
  • Chemical Synthesis
  • Halogenated Heterocycles
  • Heterocyclic Building Blocks
  • New Products for Chemical Synthesis
  • Quinazolines
Mol File:
53449-14-2.mol
More
Less

6-Nitro-7-Chloro-4-HydroxyQuinazoline Chemical Properties

Melting point:
314-319℃
Boiling point:
427.8±55.0 °C(Predicted)
Density 
1.79±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
slightly sol. in Dimethylformamide
form 
powder to crystal
pka
-2.49±0.20(Predicted)
color 
White to Light yellow to Dark green
InChI
InChI=1S/C8H4ClN3O3/c9-5-2-6-4(1-7(5)12(14)15)8(13)11-3-10-6/h1-3H,(H,10,11,13)
InChIKey
URDYTQYZXZKBQT-UHFFFAOYSA-N
SMILES
N1C2=C(C=C([N+]([O-])=O)C(Cl)=C2)C(=O)NC=1
CAS DataBase Reference
53449-14-2
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25
Safety Statements 
45
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
HS Code 
2933599590
More
Less

6-Nitro-7-Chloro-4-HydroxyQuinazoline Usage And Synthesis

Chemical Properties

Yellow or light yellow powder

Synthesis

31374-18-2

53449-14-2

General procedure for the synthesis of 7-chloro-4-hydroxy-6-nitroquinazoline from 7-chloro-4(3H)-quinazolinone: Concentrated sulfuric acid (10 mL) and concentrated nitric acid (5 mL) were added to a 100 mL round-bottomed flask, followed by 7-chloro-4(3H)-quinazolinone (10 g, 55.4 mmol). The reaction mixture was stirred at 0 °C, then slowly heated to 90 °C and stirred continuously at this temperature for 3 hours. After completion of the reaction, the mixture was cooled to room temperature and carefully poured into ice water. The precipitate was collected by filtration, washed well with water and then dried. The crude product was purified by recrystallization from acetic acid to give 7-chloro-6-nitroquinazolin-4(3H)-one (6c) as a light yellow solid (9 g, 72% yield). The melting point of the product was 315-316 °C; 1H NMR (DMSO-d6, ppm): δ 12.79 (broad peak, 1H), 8.67 (single peak, 1H), 8.31 (single peak, 1H), 8.01 (single peak, 1H).

References

[1] Medicinal Chemistry Research, 2013, vol. 22, # 9, p. 4096 - 4109
[2] European Journal of Medicinal Chemistry, 2018, vol. 147, p. 227 - 237
[3] Patent: CN108484574, 2018, A. Location in patent: Paragraph 0133; 0134; 0135
[4] Patent: CN103382182, 2016, B. Location in patent: Paragraph 0272; 0273; 0276; 0277
[5] Patent: WO2008/33747, 2008, A2. Location in patent: Page/Page column 129

6-Nitro-7-Chloro-4-HydroxyQuinazolineSupplier

Chemipanda Bio-Tech Co., Ltd. Gold
Tel
+86-571-85224801; 13588483690
Email
chemipanda2010@163.com
TIANJIN PHARMACN MEDICAL TECHNOLOGY CO.,LTD.
Tel
022-60189726 18812034280
Email
188120342808@163.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com